KP Tissue (TSE:KPT) has released an update.
KP Tissue Inc. reports a significant improvement in Q1 2024 with a 6.3% revenue increase to $479.4 million and a dramatic turnaround to a $9.0 million net income, overcoming the previous year’s loss. The company’s strategic focus on facial tissue production and brand support has strengthened its market position, following the exit of competitor Kleenex from the Canadian market. Despite facing potential commodity market headwinds, KP Tissue declares a quarterly dividend and remains optimistic about maintaining its EBITDA performance in Q2 2024.
For further insights into TSE:KPT stock, check out TipRanks’ Stock Analysis page.
